Ye Weiguo

Gyre Therapeutics, Inc. · Chief Operating Officer

Ye Weiguo is listed in filings as Chief Operating Officer at Gyre Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 27, 2026, including sale activity. Recent filings connect the profile to Gyre Therapeutics, Inc. (GYRE). The current snapshot covers public activity from Mar 11, 2025 to May 27, 2026. Reported amounts are shown as $3.0K to $2.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Latest Trades

CompanyValueActionPriceLast Price
Gyre Therapeutics, Inc.GYRE$24k4k sharesSellMay 26, 2026$6.10$6.05